Florida Department of Health

Last updated
Florida Department of Health
Florida Health logo.png
Department overview
Preceding Department
  • Florida Department of Health and Rehabilitative Services
Jurisdiction Government of Florida
Headquarters Tallahassee, Florida
30°23′N84°14′W / 30.39°N 84.23°W / 30.39; -84.23
Department executive
Website www.flhealth.gov

The Florida Department of Health is responsible for protecting the public health and safety of the residents and visitors of the state of Florida. It is a cabinet-level agency of the state government, headed by a state surgeon general who reports to the governor. The department has its headquarters in Tallahassee. [1]

Contents

History

During the 1996 legislative session, the beleaguered Florida Department of Health and Rehabilitative Services was reconstructed as two entities: the Department of Health and the Florida Department of Children and Families. [2]

The Florida Department of Health [3] operates county health departments in all 67 of the state's counties. The agency employs more than 17,000 persons. It has worked on two-year-old immunizations, tobacco control, and statewide preparedness response efforts.

The Florida Department of Health is responsible for public health, including: [4]

COVID-19

On 15 February, 2023, the department published a safety alert from the State Surgeon General Joseph Ladapo warning of “a novel increase” in adverse event reports related to mRNA-based COVID-19 vaccines. [6] The federal Centers for Disease Control and Prevention (CDC) subsequently published a public response to Ladapo and the department, offering rebuttals to his "misinterpretations and misinformation" related to the Vaccine Adverse Event Reporting System. [7]

On 10 May, 2023, Ladapo issued an open letter to Food and Drug Administration Commissioner Robert Califf and CDC Director Rochelle Walensky accusing their agencies of withholding information regarding the true rate of adverse events associated with COVID-19 vaccines. [8] Ladapo issued another letter on 6 December, 2023, asking the FDA and CDC to address reports of "nucleic acid contaminants" discovered in samples of Pfizer–BioNTech and Moderna COVID-19 vaccines. [9] The FDA dismissed his concerns as "misleading" and stated that the agency stood firm in its regulatory decision making. [10] On 3 January, 2024, Ladapo called for a statewide halt of the use of mRNA COVID-19 vaccines. [11]

Related Research Articles

<span class="mw-page-title-main">Centers for Disease Control and Prevention</span> United States government public health agency to people

The Centers for Disease Control and Prevention (CDC) is the national public health agency of the United States. It is a United States federal agency under the Department of Health and Human Services, and is headquartered in Atlanta, Georgia.

<span class="mw-page-title-main">Vaccine</span> Pathogen-derived preparation that provides acquired immunity to an infectious disease

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and recognize further and destroy any of the microorganisms associated with that agent that it may encounter in the future.

The Vaccine Adverse Event Reporting System (VAERS) is a United States program for vaccine safety, co-managed by the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). VAERS is a postmarketing surveillance program, collecting information about adverse events that occur after administration of vaccines to ascertain whether the risk–benefit ratio is high enough to justify continued use of any particular vaccine.

<span class="mw-page-title-main">Biomedical Advanced Research and Development Authority</span> Government organization in Washington D.C., United States

The Biomedical Advanced Research and Development Authority (BARDA)' is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.

<span class="mw-page-title-main">Administration for Strategic Preparedness and Response</span> US government agency

The Administration for Strategic Preparedness and Response (ASPR) is an operating agency of the U.S. Public Health Service within the Department of Health and Human Services that focuses preventing, preparing for, and responding to the adverse health effects of public health emergencies and disasters. Its functions include preparedness planning and response; building federal emergency medical operational capabilities; countermeasures research, advance development, and procurement; and grants to strengthen the capabilities of hospitals and health care systems in public health emergencies and medical disasters. The office provides federal support, including medical professionals through ASPR’s National Disaster Medical System, to augment state and local capabilities during an emergency or disaster.

An Emergency Use Authorization (EUA) in the United States is an authorization granted to the Food and Drug Administration (FDA) under sections of the Federal Food, Drug, and Cosmetic Act as added to and amended by various Acts of Congress, including by the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA), as codified by 21 U.S.C. § 360bbb-3, to allow the use of a drug prior to approval. It does not constitute approval of the drug in the full statutory meaning of the term, but instead authorizes the FDA to facilitate availability of an unapproved product, or an unapproved use of an approved product, during a declared state of emergency from one of several agencies or of a "material threat" by the Secretary of Homeland Security.

<span class="mw-page-title-main">Measles resurgence in the United States</span> Sharp increase in measles cases between 2010 and 2019

Measles was declared eliminated from the United States in 2000 by the World Health Organization due to the success of vaccination efforts. However, it continues to be reintroduced by international travelers, and in recent years, anti-vaccination sentiment has allowed for the reemergence of measles outbreaks.

<span class="mw-page-title-main">COVID-19 pandemic in the United States</span>

In the United States, the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in 103,436,829 confirmed cases with 1,184,883 all-time deaths, the most of any country, and the 20th highest per capita worldwide. The COVID-19 pandemic is the deadliest disaster in the country's history.

<span class="mw-page-title-main">COVID-19 vaccine</span> Vaccine against SARS-CoV-2

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).

<span class="mw-page-title-main">Moderna COVID-19 vaccine</span> RNA COVID-19 vaccine

The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in humans aged six months, twelve years, or eighteen years and older. It provides protection against COVID-19, which is caused by infection by the SARS-CoV-2 virus. It is designed to be administered in two or three 0.5-mL doses given by intramuscular injection at an interval of at least 28 days apart.

<span class="mw-page-title-main">Africa Centres for Disease Control and Prevention</span> Public health agency of the African Union

The Africa Centres for Disease Control and Prevention is a public health agency of the African Union to support the public health initiatives of member states and strengthen the capacity of their health institutions to deal with disease threats. The Africa CDC ideas was proposed by the government of Ethiopia in 2013 during a TB/HIV special summit in Abuja, Nigeria. From 2013 to 2016, the modalities and statue of Africa CDC were developed and the specialized agency was officially launched in January 2017.

Science diplomacy is the collaborative efforts by local and global entities to solve global issues using science and technology as a base. In science diplomacy, collaboration takes place to advance science but science can also be used to facilitate diplomatic relations. This allows even conflicting nations to come together through science to find solutions to global issues. Global organizations, researchers, public health officials, countries, government officials, and clinicians have previously worked together to create effective measures of infection control and subsequent treatment. They continue to do so through sharing of resources, research data, ideas, and by putting into effect laws and regulations that can further advance scientific research. Without the collaborative efforts of such entities, the world would not have the vaccines and treatments we now possess for diseases that were once considered deadly such as tuberculosis, tetanus, polio, influenza, etc. Historically, science diplomacy has proved successful in diseases such as SARS, Ebola, Zika and continues to be relevant during the COVID-19 pandemic today.

<span class="mw-page-title-main">Pfizer–BioNTech COVID-19 vaccine</span> Type of vaccine for humans

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. It is authorized for use in humans to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus. The vaccine is given by intramuscular injection. It is composed of nucleoside-modified mRNA (modRNA) that encodes a mutated form of the full-length spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Initial guidance recommended a two-dose regimen, given 21 days apart; this interval was subsequently extended to up to 42 days in the United States, and up to four months in Canada.

<span class="mw-page-title-main">Rochelle Walensky</span> American medical scientist (born 1969)

Rochelle Paula Walensky is an American physician-scientist who served as the director of the U.S. Centers for Disease Control and Prevention from 2021 to 2023 and had also served as the administrator of the Agency for Toxic Substances and Disease Registry in her capacity as the director of the U.S. Centers for Disease Control and Prevention from 2021 to 2023. On May 5, 2023, she announced her resignation, effective June 30, 2023. Prior to her appointment at the CDC, she had served as the chief of the Division of Infectious Diseases at Massachusetts General Hospital and a professor of medicine at Harvard Medical School. Walensky is an expert on HIV/AIDS.

<span class="mw-page-title-main">Janssen COVID-19 vaccine</span> Vaccine against COVID-19

The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, a subsidiary of American company Johnson & Johnson.

<span class="mw-page-title-main">Nirav D. Shah</span> American epidemiologist, economist and attorney

Nirav Dinesh Shah is an American epidemiologist, economist and attorney. He worked as an economist and epidemiologist at the Cambodian Ministry of Health. Shah was appointed as the director of the Illinois Department of Public Health in 2015 and served in that role until 2019. He served as the director of the Maine Center for Disease Control and Prevention from 2019 to 2023. In January 2023, he was appointed as the principal deputy director of the U.S. Centers for Disease Control and Prevention and he assumed that position in March 2023. Following the resignation of Rochelle Walensky, Shah served as the acting director of the U.S. Centers for Disease Control and Prevention in July 2023 until Mandy Cohen assumed office.

<span class="mw-page-title-main">Joseph Ladapo</span> American physician

Joseph Abiodun Ladapo is the surgeon general of Florida since 2021. He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19.

Scott Andrew Rivkees is an American physician-scientist and pediatric endocrinologist, who served as State Surgeon General and Secretary of Health of Florida from June 2019 to September 2021. The majority of Rivkees' tenure coincided with the COVID-19 pandemic.

<span class="mw-page-title-main">Brian King (epidemiologist)</span> American epidemiologist (born 1982)

Brian King is an American Epidemiologist who currently serves as the Director of the Food and Drug Administration’s Center for Tobacco Products (CTP). He was appointed to his role in July 2022.

Melinda Wharton is an American epidemiologist. She was acting director for the Immunization Division in the Centers for Disease Control.

References

  1. "Florida Department of Health Contacts." Florida Department of Health. Retrieved on October 26, 2010. "Administration 4052 Bald Cypress Way Tallahassee , FL."
  2. "Florida Department of Health - FDOH" United States Department of Health and Human Services website
  3. Bush, Janice (2024-01-05). "MyAccessFlorida – New Portal Apply Online | Florida DCF". MyAccessFlorida. Retrieved 2024-01-15.
  4. "Public health". Florida Department of Health. Archived from the original on 2007-11-05. Retrieved 2007-10-03.
  5. "School Nurses". Merritt Island, Florida: Space Coast Medicine and Healthy Living. March–April 2009. pp. 21–33.
  6. Communications Office (2023-02-15). "Health Alert on mRNA COVID-19 Vaccine Safety". Florida Department of Health . Archived from the original on 2023-02-16. Retrieved 2023-02-16.
  7. Califf, Robert M.; Walensky, Rochelle P. (2023-03-10). "FDA and CDC Response to the Florida Surgeon General". Centers for Disease Control and Prevention . Archived from the original on 2023-07-01. Retrieved 2023-07-01.
  8. Ladapo, Joseph A. (2023-05-10). "Letter to Robert Califf and Rochelle Walensky" (PDF). Florida Department of Health. Archived (PDF) from the original on 2023-07-01. Retrieved 2023-07-01.
  9. Ladapo, Joseph A. (2023-12-06). "Request for Information on COVID-19 Vaccines" (PDF). Florida Department of Health. Archived (PDF) from the original on 2024-01-06. Retrieved 2024-01-06.
  10. Marks, Peter (2023-12-14). "Final Florida Surgeon General Response". Food and Drug Administration . Archived from the original on 2024-01-06. Retrieved 2024-01-06.
  11. Farrell, James (2024-01-03). "Florida Surgeon General Calls For Halt In Covid MRNA Vaccines—Citing Debunked Concerns". Forbes . Archived from the original on 2024-01-07. Retrieved 2024-01-07.